Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
13.18B | 13.01B | 12.16B | 14.88B | 16.12B | 13.98B | Gross Profit |
3.61B | 3.50B | 3.36B | 4.39B | 5.62B | 4.95B | EBIT |
1.10B | 1.09B | 725.60M | 1.77B | 3.26B | 2.45B | EBITDA |
1.80B | 1.81B | 1.35B | 1.95B | 4.28B | 3.25B | Net Income Common Stockholders |
730.80M | 746.00M | 418.00M | 1.28B | 2.38B | 1.56B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
369.40M | 1.52B | 536.80M | 430.00M | 1.47B | 1.32B | Total Assets |
17.60B | 18.38B | 16.73B | 20.16B | 20.39B | 20.07B | Total Debt |
6.52B | 7.27B | 5.95B | 6.29B | 6.34B | 6.76B | Net Debt |
6.15B | 5.75B | 5.42B | 5.86B | 4.87B | 5.44B | Total Liabilities |
9.28B | 10.31B | 8.83B | 10.06B | 10.11B | 10.71B | Stockholders Equity |
8.31B | 8.05B | 7.88B | 10.10B | 10.27B | 9.36B |
Cash Flow | Free Cash Flow | ||||
1.15B | 1.10B | 874.10M | 1.47B | 2.65B | 1.75B | Operating Cash Flow |
1.63B | 1.59B | 1.33B | 1.96B | 3.11B | 2.14B | Investing Cash Flow |
-1.31B | -1.37B | -1.17B | -1.65B | -884.60M | -643.20M | Financing Cash Flow |
-48.10M | 779.90M | -59.30M | -1.32B | -2.07B | -517.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $19.64B | 22.23 | 13.35% | 1.75% | 9.38% | 6.43% | |
78 Outperform | $14.65B | 10.55 | 38.12% | ― | -1.79% | -41.85% | |
76 Outperform | $27.01B | 20.54 | 21.65% | ― | 2.84% | -0.16% | |
73 Outperform | $21.00B | 28.95 | 8.98% | 1.15% | 7.13% | 74.73% | |
68 Neutral | $18.23B | 12.16 | 9.19% | ― | 1.25% | 26.10% | |
64 Neutral | $11.32B | 15.29 | 8.01% | ― | -0.48% | 11.47% | |
52 Neutral | $5.22B | 3.55 | -44.39% | 2.82% | 15.40% | -0.09% |
Labcorp announced that its Annual Meeting of Shareholders will be webcast live on May 15, 2025, at 9:00 a.m. ET, accessible through the Labcorp Investor Relations website. The webcast will be archived for one year, allowing stakeholders to stay informed about the company’s operations and strategic direction.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Outperform.
Labcorp Holdings demonstrates solid financial health with efficient cash flow management and moderate revenue growth. The earnings call highlighted strong strategic initiatives and revenue growth, supporting a positive outlook. However, the stock’s premium valuation and potential margin pressures warrant cautious optimism. Technical indicators suggest a neutral to slightly cautious market stance.
To see Spark’s full report on LH stock, click here.
On April 10, 2025, Labcorp Holdings Inc. announced that its Board of Directors declared a cash dividend of $0.72 per share of common stock, payable on June 11, 2025, to stockholders of record as of May 29, 2025. This decision underscores Labcorp’s commitment to returning value to its shareholders and reflects its stable financial position, potentially enhancing its attractiveness to investors.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Outperform.
Labcorp Holdings shows strong financial stability with robust cash flow and moderate revenue growth. Positive earnings call guidance and technical indicators support a favorable outlook. However, premium valuation and potential margin pressures warrant caution. The overall score reflects a stable but cautiously optimistic view of Labcorp’s stock potential.
To see Spark’s full report on LH stock, click here.
Labcorp Holdings Inc. announced it will release its financial results for the first quarter of 2025 on April 29, 2025, before the market opens. The company will host a conference call and webcast at 9 a.m. ET on the same day to discuss the results, with the earnings press release and financial information available on the Labcorp Investor Relations website.